Articles, Blogs, News and Posters
Toward Fully Autonomous Closed-Loop Molecular Discovery: Collaboration with IBM Research
Arctoris contributed to research advancing a fully autonomous, closed-loop molecular discovery platform, demonstrated through a case study targeting Janus kinase…
Advancing AI-Driven Drug Discovery Through Collaboration with the University of Cambridge
Arctoris collaborated with researchers at the University of Cambridge and King’s College London on a study demonstrating how artificial intelligence…
Arctoris in Drug Discovery World: End-to-End Automation and AI
Arctoris was featured in Drug Discovery World (DDW) in an article exploring how the integration of end-to-end laboratory automation and…
Arctoris Featured in Forbes on the Rise of Robotics in AI-Powered Drug Discovery
Arctoris was featured in Forbes as part of a wider exploration of how robotics and artificial intelligence are converging to…
Arctoris Featured in Forbes as Pioneer of the Cloud Lab for Cancer Research
Arctoris was featured in Forbes following its early recognition as a trailblazer in a brand new field: the cloud lab…
310.ai and Arctoris Partner to Pioneer AI-Designed Proteins for Cardiac Therapy
What if AI could design a brand-new protein, from scratch, to tackle heart disease? That’s no longer science fiction. In…
Arctoris and the Ulysses® Platform Featured in Drug Discovery World
Arctoris was featured in Drug Discovery World (DDW), one of the industry’s leading publications, following the launch of Ulysses®, our…
Arctoris Partners with Insilico Medicine to Combine Robotics and AI in COVID-19 Drug Discovery
Arctoris was featured in First Word Pharma following the announcement of a technology partnership with Insilico Medicine, a leading AI-driven…
Arctoris Featured in BioPharma Trend Case Study on End-to-End Drug Discovery Automation
Arctoris was featured in a BioPharma Trend case study exploring how the Ulysses® platform combines closed-loop robotics and machine learning…
Arctoris Collaborates on AI-Driven Drug Discovery for Lung Cancer
Arctoris was featured by Medicines Discovery Catapult following its collaboration with Intelligent OMICS and Medicines Discovery Catapult on a pioneering…
Frontier of Drug Discovery
Arctoris is featured as a series partner in the Biology for a Better Tomorrow digital series, an initiative created with…
Acquisition of Eli Lilly’s Automated Laboratory Platform
Arctoris was featured in Fierce Biotech following the acquisition of Eli Lilly’s Life Sciences Studio, a highly automated robotic laboratory…
Arctoris Featured in Labiotech: Collaboration with Molecule to Advance Lab Automation
Arctoris was featured in Labiotech, in an article highlighting a collaboration between the Oxford-based automation company and Swiss software firm…
Arctoris Featured in Drug Discovery World: Accelerating COVID-19 Research with the Ulysses® Platform
Arctoris was featured in a Drug Discovery World (DDW) webinar discussing how automated experimentation platforms can accelerate drug discovery, particularly…
Arctoris Featured in Fierce Biotech: Building a New Executive Leadership Team
Arctoris was featured in Fierce Biotech following a period of significant growth, highlighting the company’s expansion and the development of…
Arctoris Receives Investment from Formic Ventures
Arctoris has been featured by Formic Ventures following the firm’s investment in the company. Formic Ventures is a venture capital…
Arctoris Featured in Royal Society of Biology Series: On the Frontier of Drug Discovery
Arctoris is featured in a video from the Royal Society of Biology’s Biology for a Better Tomorrow series exploring how…
Arctoris Featured in Labiotech: Automating Cancer Research
Arctoris was featured in a Labiotech article exploring how automation technologies are transforming cancer research. The piece highlights how robotic…
Arctoris Featured in Nanalyze: Life Sciences Laboratory Automation
Arctoris was featured in an article by Nanalyze examining the growing role of automation in life sciences laboratories. The piece…
Macrocycles! The next chapter in small molecule drug discovery?
The Therapeutic Potential of Macrocycles in Drug Discovery Structural and Conformational Properties: Macrocycles exhibit distinct physicochemical characteristics that differentiate them…
Arctoris’ automated platform accelerates drug discovery
Oxford-headquartered Arctoris progresses programmes from target to hit, lead, and candidate with superior efficiency, accuracy, and confidence. Key to the company’s capabilities is the unique…